Table 4.

IRs and adjusted HRs for incident CVD according to cross categories of obesity phenotypes and hs-cTnT levels, N = 9,477

Metabolic status†	Obesity status	hs-cTnT level, ng/L	Events/n	IR/1,000 person-years (95% CI)	Adjusted,* HR (95% CI)
Metabolically healthy	Normal weight	<6 ng/L	265/1,606	7.4 (6.6–8.4)	1 (Reference)
		≥6 ng/L	93/336	14.2 (11.6–17.4)	1.48 (1.17–1.88)
	Overweight	<6 ng/L	253/1,364	8.4 (7.5–9.5)	1.09 (0.92–1.30)
		≥6 ng/L	111/361	15.2 (12.6–18.3)	1.53 (1.22–1.92)
	Obese	<6 ng/L	113/545	9.4 (7.79–11.3)	1.37 (1.10–1.71)
		≥6 ng/L	52/151	17.1 (13.0–22.4)	1.95 (1.44–2.64)
Metabolically unhealthy	Normal weight	<6 ng/L	207/788	12.9 (11.2–14.8)	1.49 (1.24–1.79)
		≥6 ng/L	124/285	25.7 (21.4–30.5)	2.23 (1.78–2.80)
	Overweight	<6 ng/L	454/1,571	13.9 (12.7–15.2)	1.56 (1.33–1.81)
		≥6 ng/L	286/641	24.4 (21.7–27.4)	2.38 (2.00–2.83)
	Obese	<6 ng/L	376/1,244	14.8 (13.4–16.4)	2.04 (1.74–2.40)
		≥6 ng/L	269/581	27.5 (24.4–31.0)	3.06 (2.57–3.65)

Boldface type indicates P < 0.05. IR, incidence rate.

^*Adjustment for age, sex, race-center, smoking status, physical activity, hs-CRP, eGFR, and NT-proBNP.

^†Metabolic healthy, fewer than two Adult Treatment Panel III criteria; metabolically unhealthy, two or more Adult Treatment Panel III criteria.